Piermont Capital Management Inc. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$204,000
-16.7%
10,870
-14.6%
0.07%
-15.0%
Q4 2017$245,000
+1.7%
12,730
-5.6%
0.08%0.0%
Q3 2017$241,000
-51.0%
13,490
-51.0%
0.08%
-43.3%
Q2 2017$492,000
+3.8%
27,523
-15.8%
0.14%
+24.8%
Q1 2017$474,000
-1.7%
32,683
+25.0%
0.11%
+2.7%
Q4 2016$482,000
-4.7%
26,153
-1.9%
0.11%
-8.3%
Q3 2016$506,00026,6630.12%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2016
NameSharesValueWeighting ↓
MQS Management LLC 10,935$255,0000.41%
GLOBEFLEX CAPITAL L P 144,692$3,370,0000.34%
CORNERCAP INVESTMENT COUNSEL INC 58,975$1,374,0000.20%
Factorial Partners, LLC 10,900$254,0000.17%
FEDERATED HERMES, INC. 3,464,335$80,684,0000.15%
Campbell & CO Investment Adviser LLC 14,800$345,0000.12%
FULLER & THALER ASSET MANAGEMENT, INC. 611,462$14,241,0000.08%
Summit Global Investments 45,900$1,069,0000.07%
RENAISSANCE GROUP LLC 63,559$1,480,0000.06%
PDT Partners, LLC 33,459$779,0000.06%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders